CHD Bioscience's Unattributed - IV Round

CHD Bioscience raised a round of funding on November 17, 2017.

CHD Bioscience is a development-stage biopharmaceutical company focused on creating novel patented products that successfully kill most deadly pathogens blamed for the rising number of healthcare-asso…

Articles about CHD Bioscience's Unattributed - IV Round: